Roswell Park Comprehensive Cancer Center graduate student Danielle Twum has received the prestigious Emerging Scholars Award from the National Cancer Institute (NCI), recognizing her among the distinguished alumni of its Continuing Umbrella for Research Excellence (CURE) programs.

Sai Yendamuri, MD, FACS, Chair of the Department of Thoracic Surgery at Roswell Park Cancer Institute, received a prestigious award at a recent international gathering of thoracic surgeons.

Khurshid Guru, MD, one of the most experienced and accomplished robotic surgeons in the world, has been named Chair of the Department of Urology at Roswell Park Comprehensive Cancer Center. James Mohler, MD, has assumed the new role of Chief of Inter-Institutional Academics and will act as Roswell Park’s point person and liaison for translational research collaborations between Roswell Park and the University at Buffalo.

The Ride For Roswell, New York State’s largest single-day cycling fundraiser, concluded its 22nd year this weekend by raising a total of $4.6 million for cancer research and patient-care programs at Roswell Park Comprehensive Cancer Center.

A new study from Roswell Park Comprehensive Cancer Center reporting the findings of the first clinical trial to evaluate the immune effects of high-dose radiation therapy followed by surgery in patients with advanced kidney cancer may also set the stage for combination treatments with immunotherapy.

An international team of researchers has performed a follow-up analysis based on a large clinical study of a maintenance therapy for patients with multiple myeloma. Philip McCarthy, MD, of Roswell Park Comprehensive Cancer Center was principal investigator of a phase III study that showed that treatment with lenalidomide following autologous hematopoietic stem cell transplant improved both progression-free survival and overall survival for newly diagnosed multiple myeloma patients.